HOLLY DOWNING: Open Payments
NPI 1215551155 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 53 payments from 21 companies in 2025. Trend: 2023 $893 · 2024 $999 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $208 |
| GlaxoSmithKline, LLC. | 5 | $126 |
| ABBVIE INC. | 5 | $110 |
| Novo Nordisk Inc | 5 | $104 |
| Amgen Inc. | 5 | $89 |
| PFIZER INC. | 4 | $68 |
| JAZZ PHARMACEUTICALS INC. | 2 | $61 |
| SANOFI-AVENTIS U.S. LLC | 2 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Insulet Corporation | 3 | $45 |
Products named: SHINGRIX, OTEZLA, NURTEC ODT, VRAYLAR, EPIDIOLEX, TZIELD, ZENPEP, Omnipod.
Industry payments across CO — which companies pay providers there.
